课题基金 / 基金详情

Using Dendrimers to Design Multivalent Therapeutic Agent

Using Dendrimers to Design Multivalent Therapeutic Agent
使用树枝状聚合物设计多价治疗剂
批准号:
7196345
负责人:
Mary J Cloninger
金额:
$6.81万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2006-12-03

项目摘要

项目成果

Mary J Cloninger的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of our research program is to probe key questions in biological chemistry using the tools of the organic chemist. Currently, we seek to understand the protein-carbohydrate interactions that are involved in cell signaling; ultimately, we plan to use this information to formulate multivalent therapeutic agents and vaccines. In this proposal, we describe a novel dendrimer-based system from which artificial multivalent carbohydrate-containing systems will be developed. The techniques we're developing make our system uniquely suited for probing the underlying causes of the multivalent effect in protein- carbohydrate interactions. In addition, the new methods we describe for rapid synthesis of heterogeneously-functionalized dendrimer surfaces are widely applicable. A new method for incorporation of varying concentrations of mannose units onto the surface of G(4)- and G(6)-PAMAM dendrimers is outlined. Evaluation of the interaction of carbohydrate-functionalized dendrimers with lectins using microcalorimetry, hemagglutination, an enzyme-linked lectin assay, and an affinity column/EPR study is proposed. A strategy for EPR characterization of the new dendrimer motifs using TEMPO-labeled dendrimers is also presented.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Symposium funding request for "Multivalent Drug Design"
Using Dendrimers to Design Multivalent Therapeutic Agents
Using Dendrimers to Design Multivalent Therapeutic Agents
Using Dendrimers to Design Multivalent Therapeutic Agents
海外基金